FDA Inspection 1253468 — Gulf Coast Regional Blood Center

Gulf Coast Regional Blood Center — FEI 3005096242

The FDA completed an inspection of Gulf Coast Regional Blood Center on October 30, 2024 in Lufkin, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 30, 2024
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Lufkin, TX (United States)